Robert Arch
Net worth: - $ as of 31/03/2024
Profile
Robert H.
Arch served as President, CEO & Non-Independent Director at OncoSec Medical, Inc. from 2022 to 2023.
Prior to that, he was Head-Research at Elpiscience Biopharma Ltd.
from 2019 to 2021 and Head-Liver Disease Department at China Novartis Institutes for BioMedical Research Co., Ltd.
from 2017 to 2019.
Arch holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Former positions of Robert Arch
| Companies | Position | End |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 14/06/2023 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
| China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01/10/2019 |
Training of Robert Arch
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Private companies | 2 |
|---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Stock Market
- Insiders
- Robert Arch
